Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px
Organisation › Details

Accelrys Inc. (Nasdaq: ACCL)

Accelrys (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific foundation optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, QA/QC and manufacturing phases of product development. Accelrys offers capabilities in scientific data management, modeling and simulation, research informatics, laboratory informatics, enterprise quality management, environmental health & safety and operations intelligence for customers in science-driven industries. Using Accelrys technology, scientific innovators can access, organize, analyze and share data in unprecedented ways across the research, laboratory and manufacturing continuum, ultimately enhancing innovation, improving productivity and compliance, reducing costs and accelerating product development from research to manufacturing. Accelrys solutions are used by more than 2,000 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, CA. Accelrys employs more than 225 full-time PhD scientists. *

 

Period Start 2004-05-03 splitoff
Period End 2015-01-06 renamed before
  Group Dassault Systèmes (3DS) (Group)
  Today Biovia Corporation
  Successor Biovia Corporation
Product Industry bioinformatics (biological software and databases)
     
Region Region San Diego, CA
  Country United States (USA)
  Street 10188 Telesis Court
Suite 100
  City 92121 San Diego, CA
  Tel +1-858-799-5000
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency USD
  Annual sales 79,739,000 (revenue, consolidated (07/08)) 2008-03-31)
  Profit 1,321,000 (2008-03-31)
  Cash 76,382,000 (2008-03-31)
     
    * Document for »About Section«: 
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px




» top